Safety and Efficacy Results from a Phase I Dose-Escalation Trial of Nintedanib in Combination with Pembrolizumab in Patients with Advanced Solid Tumors (PEMBIB Trial).
Journal of clinical oncology(2018)
关键词
Combination Therapies
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要